This company seems to have been delisted
Reason: Merged with Opus Genetics
Last recorded trade on: December 26, 2024
Source: https://finance.yahoo.com/news/ocuphire-pharma-merges-opus-genetics-213102859.html
Reason: Merged with Opus Genetics
Last recorded trade on: December 26, 2024
Source: https://finance.yahoo.com/news/ocuphire-pharma-merges-opus-genetics-213102859.html
Ocuphire Pharma
OCUP
NZ$1.96
Share price
-12.03%
Change (1 day)
-31.03%
Change (1 year)
Categories
Revenue for Ocuphire Pharma (OCUP)
Revenue in 2024 (TTM): NZ$13.44 Million
According to Ocuphire Pharma's latest financial reports the company's current revenue (TTM 
) is NZ$14.06 Million. In 2023 the company made a revenue of NZ$30.12 Million a decrease over the revenue in the year 2022 that were of NZ$62.76 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Ocuphire Pharma from 2020 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | NZ$13.44 M | -55.35% |
| 2023 | NZ$30.12 M | -52.01% |
| 2022 | NZ$62.76 M | 7178.72% |
| 2021 | NZ$0.86 M | |
| 2020 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | NZ$0.37 M | -97.30% | 🇺🇸 USA |
 OPKO Health
OPK | NZ$1.15 B | 8,125.84% | 🇺🇸 USA |